前往化源商城

Biochimie 2016-06-01

Cyclometalated iridium(III) complexes as mitochondria-targeted anticancer agents.

Kai Xiong, Yu Chen, Cheng Ouyang, Rui-Lin Guan, Liang-Nian Ji, Hui Chao

文献索引:Biochimie 125 , 186-94, (2016)

全文:HTML全文

摘要

Four cyclometalated iridium(III) complexes [Ir(dfppy)2(L)](+) (dfppy = 2-(2,4-difluorophenyl)pyridine, L = 6-(pyridin-2-yl)-1,3,5-triazine-2,4-diamine, Ir1; 6-(isoquinolin-1-yl)-1,3,5-triazine-2,4-diamine, Ir2; 6-(quinolin-2-yl)-1,3,5-triazine-2,4-diamine, Ir3; 6-(isoquinolin-3-yl)-1,3,5-triazine-2,4-diamine, Ir4) have been synthesized and characterized. Distinct from cisplatin, Ir1-Ir4 could specifically target mitochondria and induced apoptosis against various cancer cell lines, especially for cisplatin resistant cells. ICP-MS results indicated that Ir1-Ir4 were taken up via different mechanism for cancer cells and normal cells, which resulted in their high selectivity. The structure-activity relationship and signaling pathways were also discussed. Copyright © 2016 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved.

相关化合物

结构式 名称/CAS号 全部文献
2-氰基喹啉 结构式 2-氰基喹啉
CAS:1436-43-7